BioticsAI CEO Robhy Bustami recently discussed the challenges of building a company in a heavily regulated healthcare space during an interview on the Build Mode podcast with host Isabelle Johannessen. The conversation focused on how the company has managed regulatory hurdles while maintaining team motivation.
Bustami outlined the reality of operating within a sector defined by strict compliance requirements and lengthy approval processes. He described the need for strategic planning to navigate what he characterized as significant bureaucratic obstacles, often referred to as red tape. The CEO emphasized that success in healthcare technology requires more than a strong product; it requires a deliberate approach to regulatory affairs.
Fundraising in a regulated environment
The discussion also touched on the topic of fundraising within the healthcare vertical. Bustami noted that investors in this space often have a different risk profile compared to those in less regulated technology sectors. He explained that securing capital involves demonstrating not only technological innovation but also a clear understanding of regulatory pathways and market access.
Bustami stated that the company’s ability to articulate its strategy for approval and reimbursement has been critical in building investor confidence. He added that the fundraising process for healthcare startups frequently requires more due diligence and a longer timeline than in other areas of technology.
Maintaining team momentum
A key part of the interview addressed how BioticsAI keeps its team motivated amid the pressures of regulatory scrutiny and slow-moving approval cycles. Bustami said that maintaining a clear vision and celebrating small milestones are essential practices. He stressed the importance of transparent communication with the team regarding both progress and setbacks.
The CEO noted that burnout is a real risk in healthcare technology due to the prolonged nature of development and approval. He advocated for a culture that prioritizes resilience and purpose, reminding the team of the ultimate impact their work has on patient care and clinical outcomes.
Reality of building in healthcare
Bustami provided a realistic assessment of the challenges facing technology startups in healthcare. He acknowledged that the sector is not for everyone, given the high barriers to entry and the substantial investment of time and resources required before reaching the market. He explained that companies must be prepared for a marathon, not a sprint.
The interview highlighted the contrast between the fast-paced iteration common in consumer technology and the methodical, evidence-based approach demanded in healthcare. Bustami emphasized that cutting corners on regulatory compliance is not an option, as it can lead to significant setbacks or failure.
Looking ahead
Bustami indicated that BioticsAI continues to focus on advancing its products through regulatory processes while expanding its commercial footprint. He suggested that the company is preparing for the next stages of development and is working to build on its existing momentum. The CEO did not provide specific dates but implied that further updates regarding regulatory milestones and funding rounds may be forthcoming as the company progresses.
Source: Build Mode podcast
